Ventyx Biosciences Stock Soars 12.42% on Bullish Sentiment

On May 22, 2025, Ventyx Biosciences' stock surged by 12.42% in pre-market trading, indicating a strong bullish sentiment among investors.

Ventyx Biosciences has received a consensus rating of Moderate Buy, reflecting a generally positive outlook from analysts. The company's average rating score is 2.75, based on three buy ratings and one hold rating. This suggests that analysts are optimistic about the company's future prospects, which could be driving the recent surge in stock price.

Additionally, the stock holds buy signals from both short and long-term Moving Averages, further supporting a positive forecast for Ventyx Biosciences. These technical indicators suggest that the stock is likely to continue its upward trend in the near future.